オプションチェーンは、Allarity Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Allarity Therapeuticsの市場センチメントを評価します。.

Allarity Therapeutics (NASDAQ:ALLR) 株価情報, オプションチェーン

Allarity Therapeutics

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics Inc

Allreal Holding Ltd

News

BCRX

BioCryst Grants 48,000 RSUs To New Hires As Employment Inducement Under Nasdaq Rule

Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) reported quarterly losses of $(2.24) per share which missed the analyst consensus estimate of $(0.09) by 2388.89 percent. This is a 505.41 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $79.95 million which beat the analyst consensus estimate of $73.23 million by 9.18 percent. This is a 6.16 percent increase over sales of $75.31 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

VNCE

Vince Holding Q4 EPS $(2.24) Misses $(0.09) Estimate, Sales $79.95M Beat $73.23M Estimate

Chardan Capital analyst Keay Nakae maintains Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and raises the price target from $300 to $325.

Price Target

Analyst Ratings

ALNY

Chardan Capital Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $325

Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) affirms FY2025 GAAP EPS guidance from $(1.95) to $(1.95) vs $(1.34) analyst estimate..

Guidance

FLGT

Fulgent Genetics Affirms FY2025 GAAP EPS Guidance of $(1.95) vs $(1.34) Est

WIIM

DUOL

Duolingo shares are trading higher after the company reported better-than-expected Q1 financial results, issued Q2 sales guidance above estimates, and raised its FY25 sales guidance.

TWLO

Twilio shares are trading higher after the company reported better-than-expected Q1 financial results.

Block shares are trading lower after the company reported worse-than-expected Q1 financial results.

Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) affirms FY2025 Adj EPS guidance from $(0.65) to $(0.65) vs $(0.66) analyst estimate. Affirms FY2025 sales outlook from $310.00 million to $310.00 million vs $310.44 million estimate.

Fulgent Genetics Affirms FY2025 Adj EPS Guidance of $(0.65) vs $(0.66) Est; Affirms FY2025 Sales Guidance of $310.00M vs $310.44M Est

RDDT

Reddit shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance above estimates.

TEAM

Atlassian shares are trading lower after the company issued Q4 sales guidance below estimates.

Impactive Capital, LP, together with its affiliates, one of the largest shareholders of WEX Inc. with an ownership interest of approximately 7.0% today issued an open letter to the Company's shareholders.

Impactive Capital Issues Letter To WEX Shareholders, Plans To Vote Against Three Directors To Push For Leadership Change

ABNB

Airbnb shares are trading lower after the company issued Q2 sales guidance with its midpoint below estimates.

Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) lowers FY2025 Adj EPS guidance from $0.98-$1.02 to $0.92-$0.98 vs $1.00 analyst estimate..

Wendy's Lowers FY2025 Adj EPS Guidance from $0.98-$1.02 to $0.92-$0.98 vs $1.00 Est

Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $0.77 by 42.86 percent. This is a 37.5 percent increase over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $264.00 million which beat the analyst consensus estimate of $259.14 million by 1.87 percent. This is a 41.34 percent decrease over sales of $450.06 million the same period last year.

CRTO

Criteo Q1 Adj. EPS $1.10 Beats $0.77 Estimate, Sales $264.00M Beat $259.14M Estimate

WisdomTree Reports AUM $115.8B

U.S. stock futures are in the green early Friday, after another winning day for the markets in the regular session on Thursday.
What Happened: The futures markets continue to inch higher following fresh signals from China that it is open to begin trade negotiations with Washington after weeks of stonewalling.
Strong earnings performance by Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>),&nbsp;Amazon.com Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Airbnb Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), amid growing trade, tariff, and geopolitical headwinds, helped lift investor sentiments following weeks of turbulence and uncertainties.
On Friday, investors will be closely watching the earnings of Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), and Apollo Global Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>), among several others.
U.S. 10-Year Treasuries are at 4.20%, while the 2-Year Treasuries are at 3.69%. The CME Group's FedWatch&nbsp;<a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html" target="_blank" rel="noreferrer noopener">tool</a>&nbsp;shows the markets pricing a 93.2% likelihood of interest rates remaining unchanged during the FOMC meeting that is scheduled to take place the first week of May, which marks a decrease from 95% on Thursday.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Futures</td>
<td class="has-text-align-center" data-align="center">Change (+/-)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Dow Jones</td>
<td class="has-text-align-center" data-align="center">0.54%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">S&amp;P 500</td>
<td class="has-text-align-center" data-align="center">0.50%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Nasdaq 100</td>
<td class="has-text-align-center" data-align="center">0.34%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Russell 2000</td>
<td class="has-text-align-center" data-align="center">1.01%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> The&nbsp;SPDR S&amp;P 500 Trust ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was up 0.71% on Monday, while the&nbsp;Invesco QQQ Trust&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq-100 Index, was up 1.31%, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;138z7gr&#x2A;_gcl_au&#x2A;MjA5Njc0MjY1My4xNzQwODM2NTUw&#x2A;_ga&#x2A;R1MxLjEuMTc0NDY0ODA3Mi4yLjAuMTc0NDY0ODA3NS4wLjAuMA..&#x2A;_ga_V7ZK73W7N0&#x2A;MTc0NTgyOTMzMy4xLjEuMTc0NTgyOTYyMy4wLjAuMA..">Benzinga Pro</a>&nbsp;data. Cues From Last Session: The markets were upbeat on Thursday, with most S&amp;P 500 sectors in the green, with tech and consumer discretionary sectors leading the charge. Healthcare, however, witnessed a steep decline, down 2.73% during the day, owing to the 11.66% pullback in Eli Lilly And Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), following its first quarter earnings. The S&amp;P 500 itself was up 0.63% during the day, closing at 5,604.14, followed by the Nasdaq Composite at 17,710.74, up 1.52%, the Dow Jones Industrial Average at 40,752.96, up 0.21%, and the small-cap gauge, Russell 2000, which was up 0.60%, closing at 1,975.86. Initial jobless claims at 241,000 came in significantly higher than the median forecast of 225,000, which soured sentiments during the day. As of Thursday, the Nasdaq 100 index was down 10.96% from its previous high of 22,222.61 points. The S&amp;P 500 index was 8.83% lower, as compared to the last record high of 6,147.43 points. On the other hand, Dow Jones was down 9.58% from its 52-week high of 45,073.63 points.</figcaption></figure>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Index</td>
<td class="has-text-align-center" data-align="center">Performance (+/-)</td>
<td class="has-text-align-center" data-align="center">Value</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Nasdaq Composite</td>
<td class="has-text-align-center" data-align="center">1.52%</td>
<td class="has-text-align-center" data-align="center">17,710.74</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">S&amp;P 500</td>
<td class="has-text-align-center" data-align="center">0.63%</td>
<td class="has-text-align-center" data-align="center">5,604.14</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Dow Jones</td>
<td class="has-text-align-center" data-align="center">0.21%</td>
<td class="has-text-align-center" data-align="center">40,752.96</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Russell 2000</td>
<td class="has-text-align-center" data-align="center">0.60%</td>
<td class="has-text-align-center" data-align="center">1,975.86</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to analyst Seth Golden, a chief market strategist at the Finom Group, the S&amp;P 500 having retraced 50% of the bear market at closing on Thursday, points towards the markets going to their all-time high.
Golden says, &#8220;Since 1956, when this occurred, the index went on to all-time highs and was higher 12 months forward 100% of the time.&#8221; 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It&#39;s official &#x2705; S&amp;P 500 has retraced 50% of the bear market on closing basis. Since 1956, when this occurred, the index went on to all-time highs and was higher 12 months forward 100% of the time! Only time the low was not in was 2022 (Jackson Hole &quot;more pain to come&quot;)<a href="https://twitter.com/search?q=%24SPX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SPX</a>… <a href="https://t.co/CeiiVqmdks">pic.twitter.com/CeiiVqmdks</a>
&mdash; Seth Golden (@SethCL) <a href="https://twitter.com/SethCL/status/1918106892418580919?ref_src=twsrc%5Etfw">May 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The only time this didn&#8217;t happen, says Golden, was in 2022, when Fed Chair Jerome Powell made his infamous &#8220;more pain to come&#8221; speech, leading to steeper declines in the market.
Upcoming Economic Data:
<ul>
<li>U.S. Non-Farm Payrolls, U.S. Unemployment Rate, U.S. Hourly Wages, and Hourly Wages Year-Over-Year are all set to be announced by 8:30 AM ET on Friday. </li>
<li>Factory Orders report for March is scheduled to be announced by 10 AM ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) is set to release its earnings on Friday, and while there is no clarity on the timing of the announcement, the stock is up 1.12% pre-market. Analysts expect the company to report $4.72 per share in earnings, on $81.59 billion in revenue. </li>
<li>Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) will be releasing its earnings at 9:30 AM, with analysts expecting $1.73 per share earnings, on $86.1 billion in revenue. The stock is up 0.87% pre-market. </li>
<li>Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is scheduled to announce its first quarter earnings by 11:00 AM, with consensus estimates pegging its earnings at $2.15 per share, on $48.4 billion in revenue. The stock is up 0.66% pre-market. </li>
<li>The Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) will be releasing its first quarter earnings before markets open at 8:30 AM, with the stock trading up 1.16% pre-market. Analysts expect $6.35 earnings per share, on $60.4 billion in revenue. </li>
<li>Apollo Global Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is up 1.23% pre-market, with the company expected to release its first quarter earnings before markets open at 8:30 AM. Analysts expect $1.84 in earnings, on $964 million in revenue.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures are down for the day by 0.65%, trading at $58.87 per barrel, amid growing concerns of a recession and oversupply.
Gold Spot US Dollar has finally broken free from its losing streak, and is up 1.31% on Friday, trading at $3,259.42 per ounce, which is still considerably lower than $3,500.33 per ounce last week. The U.S. Dollar Index is down 0.48%, trading at 99.7175 at the time of writing.
All Asian, Australian, and New Zealand markets are in the green on Friday, barring China&#8217;s Shanghai Index which is marginally lower. 
Image via Shutterstock

Analyst Color

Equities

Markets

General

AAPL

AMZN

MSFT

TSLA

US Futures Rise As Apple, Amazon, Airbnb Earnings Boost Market Sentiment: S&P 500 Hits Milestone That's Preceded A 100% Win Rate Since 1956, Says Expert

WisdomTree Q1 Adj. EPS $0.16 Beats $0.15 Estimate, Sales $108.08M Miss $109.06M Estimate

Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.21 by 33.33 percent. This is a 380 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $211.83 million which beat the analyst consensus estimate of $206.65 million by 2.51 percent. This is a 107.42 percent increase over sales of $102.13 million the same period last year.

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

Perella Weinberg Q1 Adj. EPS $0.28 Beats $0.21 Estimate, Sales $211.83M Beat $206.65M Estimate

Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is a 13.04 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $523.47 million which missed the analyst consensus estimate of $525.41 million by 0.37 percent. This is a 2.11 percent decrease over sales of $534.75 million the same period last year.

Wendy's Q1 Adj. EPS $0.20, Inline, Sales $523.47M Miss $525.41M Estimate

Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.18) by 122.22 percent. This is a 500 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $73.46 million which beat the analyst consensus estimate of $71.26 million by 3.10 percent. This is a 13.92 percent increase over sales of $64.48 million the same period last year.

Fulgent Genetics Q1 Adj. EPS $0.04 Beats $(0.18) Estimate, Sales $73.46M Beat $71.26M Estimate

Press Releases

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Penny Stocks

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Biotech

Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025

Comments

Allarity Therapeutics

Allarity Therapeutics (ALLR) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル